Filing Flows › Astrana Health (ASTH) › Guidance history
Astrana Health (ASTH) guidance history: what it guided and what it reported
Astrana Health gave guidance in 12 earnings releases on file since May 7, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.9% against the guided midpoint. Its releases raised guidance 6 times and lowered it once.
Revenue
Met or beat 2 of 2 periods (1 above, 1 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2025 | $2.5B (Feb 27, 2025) → raised $3.1B–$3.3B (Jul 2, 2025) | $3.2B | within the range | -0.6% |
| FY2024 | $1.6B (May 7, 2024) → raised $1.8B (Aug 7, 2024) → raised $1.9B (Nov 7, 2024) | $2.0B | above the range | +4.3% |
Net income
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $54.0M (Mar 2, 2026) | — | to be reported | — |
| FY2025 | $62.5M (Feb 27, 2025) → reaffirmed $62.5M (May 8, 2025) | — | — | — |
| FY2024 | $61.0M (May 7, 2024) → lowered $54.0M (Aug 7, 2024) | — | — | — |
EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | $1.28 (May 7, 2024) → lowered $1.12 (Aug 7, 2024) | — | — | — |
Interest expense
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $51.0M (Mar 2, 2026) | — | to be reported | — |
| FY2025 | $16.0M (Feb 27, 2025) → reaffirmed $16.0M (May 8, 2025) | — | — | — |
| FY2024 | $14.5M (May 7, 2024) → raised $18.0M (Aug 7, 2024) → raised $18.8M (Nov 7, 2024) | — | — | — |
Depreciation & amortization
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $65.0M (Mar 2, 2026) | — | to be reported | — |
| FY2025 | $32.5M (Feb 27, 2025) → reaffirmed $32.5M (May 8, 2025) | — | — | — |
| FY2024 | $14.5M (May 7, 2024) → raised $28.5M (Aug 7, 2024) → lowered $27.5M (Nov 7, 2024) | — | — | — |
Stock-based compensation
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $39.0M (Mar 2, 2026) | — | to be reported | — |
| FY2025 | $21.0M (Feb 27, 2025) → reaffirmed $21.0M (May 8, 2025) | — | — | — |
| FY2024 | $27.0M (May 7, 2024) → reaffirmed $27.0M (Aug 7, 2024) → raised $32.0M (Nov 7, 2024) | — | — | — |
The latest quarter
Astrana Health, Q3 2026: revenue $1.0B (+7% year over year), operating margin 3.9%, net earnings $13.0M, operating cash flow $16.3M. The chart follows the revenue to costs, profit and cash.
Questions
Does Astrana Health beat its guidance?
Astrana Health gave guidance in 12 earnings releases on file since May 7, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.9% against the guided midpoint.
How often does Astrana Health raise guidance?
Its earnings releases raised guidance 6 times and lowered it once since May 7, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.